Metformin Postpartum for GDM RCT for Reduced Weight Retention

Completed · Phase 4 · Has a placebo group

Conditions studied: Diabetes, Gestational

In brief

The purpose of this study is to determine whether the study drug metformin is helpful in reducing weight after pregnancy in women with gestational diabetes. This pilot study will provide information on how well women are able to take metformin postpartum, whether metformin increases weight loss, and whether there are any increased risks of side effects to you as a new mother.

Key facts

Study ID

NCT01280409

Run by

The University of Texas Health Science Center, Houston

People needed

114

Starts

2011-01-01

Expected to finish

2014-08-01

Last updated by the study team

2018-11-28

Who can join

Age: 18 and older, up to 49. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Postpartum women with a delivery greater than 34 weeks of pregnancy
• Between the ages of 18 to 49 years
• Women with a diagnosis of gestational diabetes mellitus (either treated with insulin, oral hypoglycemic agent or diet-controlled) after 24 weeks in most recent pregnancy based on a confirmatory 3 hour glucola test (based on either the Carpenter and Coustan's of the Diabetes Task Force criteria)

You may not qualify if…

• women with pre-gestational diabetes mellitus (either Type I or Type II DM)
• women unable to tolerate metformin based on patient history
• women who will be discharged hom eon insulin or oral hypoglycemic agent in the immediate postpartum period
• women with a BMI <25 kg/m²

Where it is running

• Memorial Hermann Hospital, Texas Medical Center — Houston, Texas, United States
• University of Texas Health Science Center at Houston, Professional Building — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.